CAT No: CP27857
CAS No:1217840-61-3
Synonyms/Alias:1217840-61-3;Fmoc-N-Me-His(Trt)-OH;fmoc-nalpha-methyl-n-im-trityl-l-histidine;L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-1-(triphenylmethyl)-;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanoic acid;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-(1-tritylimidazol-4-yl)propanoic acid;MFCD04974256;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-[1-(triphenylmethyl)-1H-imidazol-4-yl]propanoic acid;Fmoc-MeHis(Trt)-OH;SCHEMBL17991592;Fmoc-N-Me-His(Trt)-OH, 95%;AKOS027325791;HY-W142161;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-3-[1-(triphenylmethyl)imidazol-4-yl]propanoic acid;AS-73695;DA-53343;CS-0201943;Fmoc-N-alpha-methyl-N-Im-trityl-L-histidine;Na-(((9H-Fluoren-9-yl)methoxy)carbonyl)-Na-methyl-Nt-trityl-L-histidine;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.